AttendMe Owl Logo
AttendMe
Evidence Evolution
Internal MedicineInternal Medicine

How This Evidence Evolved

Acute Kidney Injury Prevention

From NAC Myths to Biomarker-Guided Bundles

12.5

Timeline

Signal

Early observations and pilot data that first suggested a new direction

AKI carries high short-term mortality: an e-alert cohort of community-acquired AKI reported 25% mortality within 30 days. Tepel 2000 tested NAC plus hydration in 83 patients with chronic renal insufficiency undergoing CT. Creatinine rose at least 0.5 mg/dL at 48 hours in 2% with NAC versus 21% with placebo (RR 0.1, 95% CI 0.02–0.9). PRESERVE later described widespread use of NAC and sodium bicarbonate after angiography without definitive evidence of efficacy; its larger trial tested those strategies.
Proof

Landmark RCTs and pivotal trials that established the evidence base

PRESERVE randomized 5177 high-risk angiography patients in a factorial comparison; 4993 entered the modified intention-to-treat analysis. Its 90-day composite was death, dialysis or a persistent creatinine increase of at least 50%. It occurred in 4.4% with bicarbonate versus 4.7% with saline (OR 0.93, 95% CI 0.72–1.22), and in 4.6% with NAC versus 4.5% with placebo (OR 1.02, 95% CI 0.78–1.33). Contrast-associated AKI also did not differ significantly. These results apply to the studied regimens and population; they do not demonstrate that a whole field abandoned prior practice.
Extension

Follow-up studies, subgroup analyses, and real-world validation

BigpAK tested a biomarker-triggered supportive care bundle. In the single-centre, unblinded, randomized BigpAK trial, 121 patients at high AKI risk after major abdominal surgery (urinary TIMP-2×IGFBP7 >0.3) received a KDIGO care bundle (early fluid optimization, maintenance of perfusion pressure, stopping nephrotoxic agents) or standard ICU care. Overall AKI stages did not differ, but in the subgroup with values of 0.3-2.0, AKI occurred in 27.1% vs 48.0% (P=0.03); moderate and severe AKI were also less frequent with the bundle (P=0.04). Electronic AKI alerts (e-alerts), sensitive to small creatinine changes, were used to detect community-acquired AKI: one 6-month hospital cohort found 1,277 episodes in 1,185 patients and 25% 30-day mortality.
Guidelines

Integration into clinical practice guidelines and recommendations

KDIGO 2012 provides an AKI framework; a later article presents highlights of its 2026 AKI/AKD guideline. For patients at increased risk of CI-AKI, KDIGO 2012 recommended IV isotonic sodium chloride or bicarbonate rather than no volume expansion (1A), the lowest possible contrast dose, and suggested oral NAC with IV isotonic crystalloids (2D). The 2020 ACR/NKF consensus prefers saline for IV-contrast prophylaxis when indicated, does not prefer bicarbonate, and does not recommend NAC for IV-contrast prophylaxis. KDIGO 2012, summarized in 2013, advises risk-based creatinine/urine monitoring and protocol hemodynamic/oxygenation management for high-risk perioperative patients or septic shock (2C). Its glucose target of 110–149 mg/dL applies to critically ill patients (2C), with hypoglycemia risk.
KDIGO 2012 AKI guideline — Part 1 summary

KDIGO 2012: stage AKI by creatinine/urine output; initial isotonic crystalloids in patients with or at risk of AKI, absent hemorrhagic shock (2B); protocol hemodynamic care for high-risk perioperative patients or septic shock (2C).

ACR/NKF Consensus Statement on Contrast-Associated AKI

IV contrast CI-AKI risk is lower than thought. Saline prophylaxis for AKI or eGFR <30 without maintenance dialysis; assess fluid-overload risk. NAC not recommended. Do not avoid necessary contrast CT without a suitable alternative solely for CI-AKI risk.

Now

Current standard of care and ongoing research directions

Contrast-related AKI risk requires separating association from causation. ACR/NKF notes that older studies lacked adequate controls; uncertainty remains in severe kidney disease. In BigpAK, a biomarker-triggered bundle was tested in 121 high-risk patients after major abdominal surgery: overall AKI stages did not differ, but moderate/severe AKI was less frequent. A review discusses urinary TIMP-2×IGFBP7 for early risk assessment. Questions include how NGAL, KIM-1 or AI prediction compare with existing approaches, whether alerts improve outcomes and how biomarker-triggered care should be implemented. These questions do not establish universal 12–48-hour prediction or worldwide adoption.

Landmark Trials in This Story

New England journal of medicine 2000

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

Serum creatinine rise ≥44 μmol/L at 48 hours after contrast administration

New England journal of medicineRCTN=83
PRESERVE2018Landmark

Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine

Composite of death, dialysis, or persistent ≥50% creatinine increase at 90 days

New England journal of medicine2x2 factorial RCTN=5,177
BigpAK2018

Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery: The Prospective Randomized BigpAK Study

AKI after abdominal surgery: bundle vs standard care, overall stages not different; TIMP-2×IGFBP7 0.3-2.0 subgroup 27.1% vs 48.0% (P=0.03)

Ann SurgRCTN=121
Nephron 2017

The Use of Automated Electronic Alerts in Studying Short-Term Outcomes Associated with Community-Acquired Acute Kidney Injury

30-day mortality after e-alert-detected community-acquired AKI: 25% (1,185 patients; no comparator)

NephronCohort study of community-acquired AKI detected by electronic alertsN=1,185
KDIGO 2012 (CI-AKI summary)2013

Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2).

CI-AKI prevention: IV isotonic sodium chloride or sodium bicarbonate rather than no volume expansion (1A); lowest possible contrast dose (not graded); oral NAC with IV isotonic crystalloids (2D)

Crit CareAbridged summary of the 2012 KDIGO AKI clinical practice guideline
ACR/NKF 20202020

Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation

Prophylaxis with IV normal saline indicated for AKI or eGFR <30 mL/min/1.73 m2 without maintenance dialysis; may be considered at eGFR 30-44 in individual high-risk circumstances; NAC not recommended (consensus, no trial endpoint)

Kidney MedJoint American College of Radiology and National Kidney Foundation consensus statements
KDIGO 2026 (highlights)2026

[Highlights of the Kidney Disease: Improving Global Outcomes (KDIGO) 2026 clinical practice guideline for acute kidney injury/acute kidney disease].

Highlights of the KDIGO 2026 guideline for AKI/AKD

Zhonghua Nei Ke Za Zhi
NephroCheck review2020

Evaluating Nephrocheck® as a Predictive Tool for Acute Kidney Injury.

Review of urinary TIMP-2×IGFBP7 for early AKI risk assessment and its integration with clinical care in high-risk settings.

International journal of nephrology and renovascular diseaseNarrative review

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Related Evidence

Frequently Asked Questions

Does NAC prevent contrast-induced kidney injury?+
PRESERVE did not demonstrate a preventive benefit from NAC. In PRESERVE (5,177 high-risk patients undergoing angiography), the 90-day composite of death, dialysis or persistent creatinine rise occurred in 4.6% with NAC vs 4.5% with placebo (OR 1.02, 95% CI 0.78-1.33), with no difference in contrast-associated AKI. The earlier positive trial was small (83 patients) and used a 48-hour creatinine endpoint. The 2020 ACR/NKF consensus does not recommend NAC for intravenous contrast; when prophylaxis is indicated, it prefers isotonic normal saline.
Is contrast-associated AKI as dangerous as we thought?+
The risk has been re-evaluated. The 2020 ACR/NKF consensus states that AKI risk after intravenous contrast has been overstated, because older studies lacked adequate control groups. It estimates contrast-induced AKI risk near 0% at eGFR ≥45, 0-2% at 30-44 and 0-17% below 30 mL/min/1.73 m2, and states that necessary contrast-enhanced CT without a suitable alternative should not be avoided solely for this risk. Prophylaxis with intravenous normal saline is indicated for AKI or eGFR <30 without maintenance dialysis, after considering heart-failure and hypervolemia risks, and may be considered at 30-44 in individual high-risk cases.
What are AKI biomarkers and how are they used?+
Urinary TIMP-2×IGFBP7 is discussed in a NephroCheck review as an early AKI risk tool. BigpAK tested a triggered bundle in 121 high-risk major-abdominal-surgery patients: fluid optimization, perfusion-pressure maintenance and stopping nephrotoxins. Overall AKI stages did not differ significantly, but moderate/severe AKI was less frequent. This supports that studied implementation, not universal superiority.
What is a KDIGO AKI bundle?+
KDIGO 2012 (2013 summary) organizes care by AKI risk, stage and cause. Monitor creatinine and urine output by risk and clinical course. Without hemorrhagic shock, isotonic crystalloids are suggested for initial volume expansion in patients with or at risk of AKI (2B). Protocol hemodynamic/oxygenation management is suggested for high-risk perioperative patients or septic shock (2C). BigpAK tested fluid optimization, perfusion-pressure maintenance and nephrotoxin withdrawal after high-risk abdominal surgery; moderate/severe AKI was less frequent.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026